{"id":57601,"date":"2014-08-11T10:41:22","date_gmt":"2014-08-11T14:41:22","guid":{"rendered":"http:\/\/www.bu.edu\/experts\/?post_type=profile&#038;p=57601"},"modified":"2019-10-15T15:10:01","modified_gmt":"2019-10-15T19:10:01","slug":"paul-duprex","status":"publish","type":"profile","link":"https:\/\/www.bu.edu\/prsocial\/profile\/paul-duprex\/","title":{"rendered":"Paul Duprex"},"content":{"rendered":"<p>Paul Duprex is a molecular virologist and Director of Cell &amp; Tissue Imaging at Boston University&#8217;s National Emerging Infectious Diseases Laboratory (<a href=\"http:\/\/bu.edu\/neidl\">NEIDL<\/a>).\u00a0<span>The overarching goal of his research program is to understand the molecular basis of paramyxovirus pathogenesis and attenuation with a view to translating this knowledge into the development and delivery of safe and efficacious vectored vaccines. <\/span><\/p>\n<p><span>Dr. Duprex has over fifteen years experience as a molecular virologist.\u00a0 He has worked with his laboratory to develop reverse genetics systems for both positive and negative strand RNA viruses. Currently, his group focuses on respiratory paramyxoviruses.<\/span><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"author":11144,"template":"","_links":{"self":[{"href":"https:\/\/www.bu.edu\/prsocial\/wp-json\/wp\/v2\/profile\/57601"}],"collection":[{"href":"https:\/\/www.bu.edu\/prsocial\/wp-json\/wp\/v2\/profile"}],"about":[{"href":"https:\/\/www.bu.edu\/prsocial\/wp-json\/wp\/v2\/types\/profile"}],"author":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/prsocial\/wp-json\/wp\/v2\/users\/11144"}],"version-history":[{"count":2,"href":"https:\/\/www.bu.edu\/prsocial\/wp-json\/wp\/v2\/profile\/57601\/revisions"}],"predecessor-version":[{"id":70499,"href":"https:\/\/www.bu.edu\/prsocial\/wp-json\/wp\/v2\/profile\/57601\/revisions\/70499"}],"wp:attachment":[{"href":"https:\/\/www.bu.edu\/prsocial\/wp-json\/wp\/v2\/media?parent=57601"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}